Today: 22 May 2026
Zoom Communications Stock Jumps as May 21 Earnings Test Puts AI Plan on Clock

Zoom Communications Stock Jumps as May 21 Earnings Test Puts AI Plan on Clock

San Jose, California, May 1, 2026, 13:08 PDT

  • Zoom shares last changed hands at $103.60 late Friday, a gain of $6.45 on the day. Earlier, the stock had hit an intraday peak of $104.11.
  • Mark your calendar for May 21: the company will report its first-quarter fiscal 2027 results, followed by a live investor webinar right after the market closes.
  • Proxy filings now schedule a virtual annual meeting for June 11, with shareholders set to weigh in again on board elections and executive compensation.

Zoom Communications shares jumped Friday, drawing renewed attention to the workplace software company ahead of two key dates: its first-quarter report lands May 21, with a shareholder meeting set for June 11. The rally sets up a fresh test for Zoom’s efforts to expand past video calls into areas like artificial intelligence, phone, and customer-service software—and whether those bets are starting to feed into revenue.

That’s important at this point, since Zoom isn’t just lumped in with pandemic-meeting plays anymore. The company is pitching itself as a wider work platform, and shareholders are focused on whether its AI offerings will finally push growth higher—even as profit and cash flow keep coming in solid.

Zoom announced on April 29 that it plans to release fiscal first-quarter 2027 results after the close on May 21, with a webinar set for 2:00 p.m. Pacific. Ordinarily, an earnings-date press release like this wouldn’t get much notice. This time, though, shares are up and software names with AI angles remain in the spotlight.

Zoom Communications, Inc. scheduled its virtual annual meeting for June 11 at 10:00 a.m. Pacific, according to the proxy statement filed April 30. On the agenda: shareholders set to vote on adding Eric S. Yuan and H.R. McMaster as Class I directors, a proposal to ratify KPMG as auditor through the fiscal year ending Jan. 31, 2027, and an advisory say-on-pay for executives.

That setup just got more pronounced in the tape. Zoom last traded at $103.60, a gain of 6.6% from Thursday’s close. Volume crossed 4.7 million shares, market data showed.

Zoom executives don’t want the company boxed in as just another video conferencing tool. Chief Marketing Officer Kimberly Storin told the Wall Street Journal Zoom clocks “99% brand awareness”—but she pointed to a “perception challenge,” as video alone is now seen as commodity tech by buyers chasing wider software bundles. The Wall Street Journal

Zoom’s numbers held firm, even as the brand’s narrative wobbled. Fourth-quarter revenue reached $1.247 billion, a 5.3% increase from last year. For the full fiscal year 2026, the company posted $4.869 billion in revenue, up 4.4%. Enterprise business outpaced other segments, and the count of customers bringing in more than $100,000 over the past year climbed 9.3%.

Back in February, Yuan—Zoom’s founder and chief executive—told investors he saw the company “surpass the $5 billion revenue milestone” in fiscal 2027. Zoom’s own forecast put full-year revenue between $5.065 billion and $5.075 billion, with free cash flow, meaning what’s left after capital spending, in the $1.70 billion to $1.74 billion range. GlobeNewswire

Competition is fierce, and not just in scheduled meetings. In the February earnings call, Zoom management pointed to a big win: a Fortune 10 client dropped Cisco Calling in favor of 140,000 Zoom Phone seats. Zoom also claimed it bumped out both Teams and Cisco Calling at two major U.S. financial firms. For investors, Microsoft Teams and Cisco still serve as the main benchmarks as they try to gauge Zoom’s ability to land big enterprise contracts beyond its core video offering.

Shareholder demands aren’t far off, either. Last week, Spruce Point Capital Management came out with a strong-buy on Zoom, disclosing a long position and saying it stands to gain if shares climb. The activist urged Zoom’s board to look at a $4 billion modified Dutch auction tender, a $1-a-share dividend, aggressive cost reductions, and changes to the dual-class structure.

This setup isn’t straightforward. Zoom flags a laundry list of risks—anything from fewer new customers or slower renewals and upgrades, to stiffer competition, weak macro conditions, drawn-out sales cycles with big clients, outages, even security problems. If May numbers bring AI buzz but don’t deliver a billing pop or a more bullish outlook, Friday’s rally could look premature.

The calendar handles part of the heavy lifting here: numbers hit on May 21, then the shareholder vote lands June 11. The tougher task? Convincing investors that Zoom’s AI, phone, and customer experience offerings represent real growth, not just bolt-ons to its meetings core.

Stock Market Today

  • Q1 Earnings Review: Azenta Falls; West Pharmaceutical Leads Drug Development Services Stocks
    May 21, 2026, 9:31 PM EDT. Drug development inputs and services stocks, essential for pharmaceutical research and manufacturing, reported mixed Q1 results. Azenta (NASDAQ:AZTA), specializing in biological sample management, posted disappointing results with $144.8 million revenue, missing estimates and the weakest among peers, causing its share price to drop 23.4% to $17.65. Conversely, West Pharmaceutical Services (NYSE:WST), maker of specialized packaging and delivery devices, delivered a strong quarter with $844.9 million revenue, beating estimates by 8.4%. Overall, the sector's revenues beat consensus by 1.6%, despite an average 2.5% share price decline post-earnings. Tailwinds include growth in biologics and gene therapies, while headwinds feature pricing pressure and regulatory risks.

Latest articles

OpenAI Shares Hype Returns, Still No Ticker in Sight

OpenAI Shares Hype Returns, Still No Ticker in Sight

22 May 2026
OpenAI is preparing to confidentially file for a U.S. IPO, aiming to go public as early as September, sources told Reuters. The move follows a court win against Elon Musk, removing a key legal obstacle. Private-market share prices for OpenAI ranged from $658.94 to $732.38 this month, but no official public price exists. Ordinary investors still cannot buy OpenAI stock on public exchanges.
Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

Estée Lauder Shares Gain as Rumored Deal Fails to Materialize

22 May 2026
Estée Lauder and Spain’s Puig ended merger talks that would have created a $40 billion beauty group. Estée Lauder shares rose about 10% in after-hours trading, closing the regular session at $78.91. The company said it will focus on its turnaround plan and continue reviewing possible acquisitions or divestitures.
WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

WhiteFiber Stock Rips 22% on $160 Million AI Deal. The Test Comes in July

22 May 2026
WhiteFiber shares jumped 22.2% to $29.55 after announcing a five-year AI compute contract worth over $160 million for a Paris-region deployment using NVIDIA GPU systems. Google Finance showed the stock rising further after hours. The project is backed by planned financing and 12 months of customer prepayments, but funding and execution remain pending. Service is expected to start in July, subject to equipment delivery and acceptance.
GameStop’s $9 Billion Cash Pile Just Put Its Stock Back In Play
Previous Story

GameStop’s $9 Billion Cash Pile Just Put Its Stock Back In Play

Oracle Stock Jumps After Pentagon AI Win, OpenAI Reassurance
Next Story

Oracle Stock Jumps After Pentagon AI Win, OpenAI Reassurance

Go toTop